Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAM | Class A Common | Award | $0 | +658 | +14.39% | $0.00 | 5.23K | Mar 1, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAM | March 1, 2020 Stock Option | Award | $0 | +556 | +49.96% | $0.00 | 1.67K | Mar 1, 2022 | Class A Common | 1.67K | $370.79 | Direct | F3 |
transaction | SAM | March 1, 2022 Stock Option | Award | $0 | +1.42K | $0.00 | 1.42K | Mar 1, 2022 | Class A Common | 1.42K | $383.46 | Direct | F4 |
Id | Content |
---|---|
F1 | Represents a grant of Restricted Stock Units ("RSUs") under the Issuer's Restated Employee Equity Incentive Plan ("EEIP"). The RSUs will vest in four equal installments over a four year period, provided that the Reporting Person remains employed by the Issuer on the applicable vesting date, and subject to accelerated vesting in certain situations. |
F2 | The shares reported include 4,193 shares of restricted stock subject to vesting conditions. The Reporting Person had a total of 219 RSUs vest on March 1, 2022. |
F3 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2020. The extent to which the options were exercisable was dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2021 over Fiscal Year 2019. In February 2022, the Compensation Committee determined that the performance criteria had been achieved, and as such the options vest in three equal installments on March 1 in the years 2022-2024, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |
F4 | The Performance-Based Stock Options were granted pursuant to the Issuer's EEIP on March 1, 2022. The extent to which the options become exercisable is dependent upon the Company achieving certain compounded annual growth rate targets based on net revenue growth in Fiscal Year 2023 over Fiscal Year 2021. The Compensation Committee will determine if the performance criteria have been achieved prior to March 1, 2024. If the performance criteria is achieved, the options vest in three equal installments on March 1 in the years 2024-2026, provided that the Reporting Person remains employed by the Company on the applicable vesting dates, and subject to accelerated vesting in certain situations. |